Home

Despică Am fost surprins Peer temozolomide mouse Recuzită mijloace Lupta

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma |  Journal for ImmunoTherapy of Cancer
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma | Journal for ImmunoTherapy of Cancer

A combined treatment regimen of MGMT-modified γδ T cells and temozolomide  chemotherapy is effective against primary high grade gliomas | Scientific  Reports
A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas | Scientific Reports

Combination Treatment of Temozolomide and Olaparib PARP Inhibitor... |  Download Scientific Diagram
Combination Treatment of Temozolomide and Olaparib PARP Inhibitor... | Download Scientific Diagram

Combination therapy in a xenograft model of glioblastoma: enhancement of  the antitumor activity of temozolomide by an MDM2 antagonist in: Journal of  Neurosurgery Volume 126 Issue 2 (2017) Journals
Combination therapy in a xenograft model of glioblastoma: enhancement of the antitumor activity of temozolomide by an MDM2 antagonist in: Journal of Neurosurgery Volume 126 Issue 2 (2017) Journals

Developing a clinically relevant radiosensitizer for temozolomide-resistant  gliomas | PLOS ONE
Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas | PLOS ONE

Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective  against Temozolomide-Resistant Brain Cancer in Cell Culture | ACS Chemical  Biology
Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture | ACS Chemical Biology

Depletion of adult neurogenesis using the chemotherapy drug temozolomide in  mice induces behavioural and biological changes relevant to depression |  Translational Psychiatry
Depletion of adult neurogenesis using the chemotherapy drug temozolomide in mice induces behavioural and biological changes relevant to depression | Translational Psychiatry

Frontiers | Combination of Endothelial-Monocyte-Activating Polypeptide-II  with Temozolomide Suppress Malignant Biological Behaviors of Human  Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR  Signal Pathway
Frontiers | Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway

Combining Temozolomide and lysate in a curative treatment improves... |  Download Scientific Diagram
Combining Temozolomide and lysate in a curative treatment improves... | Download Scientific Diagram

20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains  epithelial‐mesenchymal transition progression in glioblastoma - Chen - 2019  - Cancer Science - Wiley Online Library
20(S)‐ginsenoside‐Rg3 reverses temozolomide resistance and restrains epithelial‐mesenchymal transition progression in glioblastoma - Chen - 2019 - Cancer Science - Wiley Online Library

TMZ in GBM models in vivo. (A) Intravenous TMZ treatment of... | Download  Scientific Diagram
TMZ in GBM models in vivo. (A) Intravenous TMZ treatment of... | Download Scientific Diagram

A novel enhancer regulates MGMT expression and promotes temozolomide  resistance in glioblastoma | Nature Communications
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma | Nature Communications

Enhanced efficacy of combined temozolomide and bromodomain inhibitor  therapy for gliomas using targeted nanoparticles | Nature Communications
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles | Nature Communications

Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant  and Immunosuppressive Microenvironment in Orthotopic Glioblastoma | ACS Nano
Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma | ACS Nano

Frontiers | A Potential Mechanism of Temozolomide Resistance in  Glioma–Ferroptosis
Frontiers | A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma |  Journal for ImmunoTherapy of Cancer
Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma | Journal for ImmunoTherapy of Cancer

Combination of temozolomide with immunocytokine F16–IL2 for the treatment  of glioblastoma | British Journal of Cancer
Combination of temozolomide with immunocytokine F16–IL2 for the treatment of glioblastoma | British Journal of Cancer

Improved Brain Penetration and Antitumor Efficacy of Temozolomide by  Inhibition of ABCB1 and ABCG2 - ScienceDirect
Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2 - ScienceDirect

287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human  Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme:  Molecular Therapy
287. Improved Outcomes Following Drug-Resistant Immunotherapy in a Human Xenograft Model of Temozolomide-Resistant Glioblastoma Multiforme: Molecular Therapy

Convection-enhanced delivery of temozolomide and whole cell tumor  immunizations in GL261 and KR158 experimental mouse gliomas | BMC Cancer |  Full Text
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas | BMC Cancer | Full Text

Adaptive Immune Response to and Survival Effect of Temozolomide- and  Valproic Acid-induced Autophagy in Glioblastoma | Anticancer Research
Adaptive Immune Response to and Survival Effect of Temozolomide- and Valproic Acid-induced Autophagy in Glioblastoma | Anticancer Research

Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles  Functionalized with Anti-EphA3 for Glioblastoma Targeting | Molecular  Pharmaceutics
Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting | Molecular Pharmaceutics